These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 23731275)

  • 21. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
    Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
    Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues.
    Torres A; Torres K; Wdowiak P; Paszkowski T; Maciejewski R
    Gynecol Oncol; 2013 Sep; 130(3):588-94. PubMed ID: 23811003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.
    Xu Z; Zeng X; Tian D; Xu H; Cai Q; Wang J; Chen Q
    Biochem Biophys Res Commun; 2014 Oct; 453(4):833-8. PubMed ID: 25450356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
    Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
    Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
    Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.
    Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma.
    Kong WQ; Bai R; Liu T; Cai CL; Liu M; Li X; Tang H
    FEBS J; 2012 Apr; 279(7):1252-60. PubMed ID: 22325466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.
    Shang C; Lu YM; Meng LR
    Med Sci Monit; 2012 Apr; 18(4):BR149-55. PubMed ID: 22460089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of claudin-4 in the diagnosis and treatment of endometrial carcinoma].
    Pan XY; Li X; Che YC; Li X; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):768-71. PubMed ID: 24406135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane expression of the death ligand trail receptors DR4 and DR5 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer.
    Gottwald L; Szwalski J; Piekarski J; Pasz-Walczak G; Kubiak R; Spych M; Suzin J; Tyliński W; Sęk P; Jeziorski A
    J Obstet Gynaecol; 2013 Jul; 33(5):512-8. PubMed ID: 23815209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model.
    Hu QL; Jiang QY; Jin X; Shen J; Wang K; Li YB; Xu FJ; Tang GP; Li ZH
    Biomaterials; 2013 Mar; 34(9):2265-76. PubMed ID: 23298779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.